We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





New Rapid Test That Identifies Deteriorating COVID-19 Patients with Greater Accuracy than Existing Tests Presented at AACC 2021

By LabMedica International staff writers
Posted on 28 Sep 2021
Print article
Illustration
Illustration

A groundbreaking study on a new rapid test that identifies COVID-19 patients who will deteriorate with greater accuracy than existing tests was presented at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

A team of researchers from MeMed (Haifa, Israel) has developed the test that predicts COVID-19 outcomes with high accuracy. In 15 minutes, the test measures blood levels of TRAIL and IP-10, two proteins that the immune system produces in response to viral infections, and CRP, a general marker of infection severity. The test then uses these values to calculate a COVID-19 Severity score on a scale of 0-100, with 100 indicating the highest likelihood of severe outcome.

To develop this test, the researchers first used a rapid point-of-care instrument that MeMed previously built to measure TRAIL, IP-10, and CRP in a group of 518 COVID-19 patients, 113 of whom had a severe outcome. The researchers analyzed the data from this group with a machine learning algorithm in order to create the model that serves as the basis for the COVID-19 Severity score. Through statistical analysis, the researchers then determined that the COVID-19 Severity score has an area under the curve (AUC) of 0.86. This means that it outperforms other COVID-19 severity stratification tests in terms of accuracy, including the commonly used biomarker IL-6, which only has an AUC of 0.77.

“There are three elements that are novel about this test,” said Eran Eden, PhD, Co-founder & CEO of MeMed. “First, we’re using the body’s immune response to tell us what’s going on with the patient. Second, instead of using just one biomarker, we’re combining three complementary markers to get a more holistic picture. And third, we’re using a novel platform that is able to measure these specific proteins from blood within 15 minutes, making this test clinically applicable to the workflow in today’s emergency departments.”

Related Links:
MeMed

Gold Member
Troponin T QC
Troponin T Quality Control
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Chagas Disease Test
Simple/Stick Chagas/WB
New
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)

Print article
ADLM

Channels

Molecular Diagnostics

view channel
Image: The groundbreaking genomics method has the potential to uncover insights previously missed (Photo courtesy of Breakthrough Genomics)

Groundbreaking Blood Test Detects Earliest Signs of Pancreatic Cancer Before Symptoms Appear

Pancreatic cancer often remains undetected until it has progressed beyond the pancreas, typically because it presents no noticeable symptoms in its early stages. Consequently, pancreatic cancer has one... Read more

Hematology

view channel
Image: The new test could improve specialist transplant and transfusion practice as well as blood banking (Photo courtesy of NHS Blood and Transplant)

New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape

The release of oxygen by red blood cells is a critical process for oxygenating the body's tissues, including organs and muscles, particularly in individuals receiving large blood transfusions.... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: The iFAST reader scans 5000 individual bacteria with each sample analyzed in less than a minute (Photo courtesy of iFAST)

High-Throughput AST System Uses Microchip Technology to Rapidly Analyze Bacterial Samples

Bacteria are becoming increasingly resistant to antibiotics, with resistance levels ranging from 20% to 98%, and these levels are unpredictable. Currently, antimicrobial susceptibility testing (AST) takes... Read more

Pathology

view channel
Image: These images show the high resolution achieved with the new microscopy technique (Photo courtesy of Cao, R. et al. Science Advance, 2024. Caltech)

New Microscopy Technique Enables Rapid Tumor Analysis by Surgeons in OR

The current standard method for quickly sampling and imaging tissue during surgery involves taking a biopsy, freezing the sample, staining it to enhance visibility, and slicing it into thin sections that... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.